{"cik":1855485,"taxonomy":"us-gaap","tag":"CurrentIncomeTaxExpenseBenefit","label":"Current Income Tax Expense (Benefit)","description":"Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.","entityName":"Calidi Biotherapeutics, Inc.","units":{"USD":[{"start":"2022-01-01","end":"2022-12-31","val":11000,"accn":"0001493152-24-010158","fy":2023,"fp":"FY","form":"10-K","filed":"2024-03-15","frame":"CY2022"},{"start":"2023-01-01","end":"2023-12-31","val":16000,"accn":"0001493152-24-010158","fy":2023,"fp":"FY","form":"10-K","filed":"2024-03-15"},{"start":"2023-01-01","end":"2023-12-31","val":16000,"accn":"0001641172-25-001810","fy":2024,"fp":"FY","form":"10-K","filed":"2025-03-31","frame":"CY2023"},{"start":"2024-01-01","end":"2024-12-31","val":14000,"accn":"0001641172-25-001810","fy":2024,"fp":"FY","form":"10-K","filed":"2025-03-31"},{"start":"2024-01-01","end":"2024-12-31","val":14000,"accn":"0001493152-26-013242","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-27","frame":"CY2024"},{"start":"2025-01-01","end":"2025-12-31","val":15000,"accn":"0001493152-26-013242","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-27","frame":"CY2025"}]}}